Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.973
+0.008 (0.81%)
At close: Mar 9, 2026, 4:00 PM EDT
1.000
+0.027 (2.78%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Senti Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
34
Market Cap
25.57M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Barinthus Biotherapeutics | 14.97M |
| Evaxion | 7.53M |
| Cue Biopharma | 7.10M |
| IGC Pharma | 1.11M |
| Vistagen Therapeutics | 789.00K |
| Exicure | 500.00K |
| Hyperion DeFi | 345.32K |
SNTI News
- 6 days ago - Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 13 days ago - Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 17 days ago - Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development - GlobeNewsWire
- 26 days ago - Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) - GlobeNewsWire
- 4 weeks ago - Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026 - GlobeNewsWire
- 7 weeks ago - Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company's Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation - GlobeNewsWire
- 2 months ago - Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Senti Biosciences Announces New Employment Inducement Grants - GlobeNewsWire